Euclidean Capital LLC
Annual return '25
-86.8%
SPY '25
+17.7%
Alpha
-104.5ptsvs SPY
Invested
$392.3M
Holdings
10
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$VEU
VANGUARD INTL EQUITY INDEX F
Q4 2025: Exited (was 2.58M shares)
62.1%
02
$VTV
VANGUARD INDEX FDS
Q4 2025: New position (2.1k shares)
26.0%
03
$INDA
ISHARES TR
Q4 2025: Exited (was 369.6k shares)
4.4%
04
$ORIC
ORIC PHARMACEUTICALS INC
Q4 2025: Exited (was 989.4k shares)
3.2%
05
$FHTX
FOGHORN THERAPEUTICS INC
Q4 2025: Exited (was 1.57M shares)
1.9%
06
$PMVP
PMV PHARMACEUTICALS INC
Q4 2025: Exited (was 2.63M shares)
0.8%
07
$ALEC
ALECTOR INC
Q4 2025: Exited (was 1.31M shares)
0.7%
08
$SRZN
SURROZEN INC
Q4 2025: Exited (was 87.7k shares)
0.7%
09
$TNYA
TENAYA THERAPEUTICS INC
Q1 2026: Sold 8.7% (31.4k → 28.7k shares)
0.2%
10
$SRZNW
SURROZEN INC
Q4 2025: Exited (was 170.8k shares)
0.0%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 14:02 UTC.